DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Amphotericin B (Amphotericin B) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Amphotericin B and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (102)
Death (44)
Life Threatening Events (14)
Disability (1)

Reports by Reaction Type

Immune Reconstitution Syndrome (14)Renal Failure Acute (14)Renal Impairment (10)Drug Ineffective (8)Pyrexia (8)Bronchopulmonary Aspergillosis (8)Dyspnoea (8)Liver Injury (7)Meningitis (7)Renal Failure (7)Respiratory Failure (7)Diarrhoea (7)

Below are a few examples of reports where side effects / adverse reactions may be related to Amphotericin B. For a complete list or a specific selection of reports, please use the links above.

Possible Amphotericin B side effects in male

Reported by a physician from Germany on 2012-08-24

Patient: male, weighing 48.0 kg (105.6 pounds)

Reactions: Memory Impairment

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Granisetron
    Dosage: 3 mg, per day
    Start date: 2012-08-08
    End date: 2012-08-11

Sulfamethoxazole and Trimethoprim
    Dosage: 2x120mg every sat, sun and mon
    Administration route: Oral

Cytarabine
    Dosage: 110 mg, per day
    Start date: 2012-08-08
    End date: 2012-08-11

Furosemide
    Dosage: 2x10mg/d
    Start date: 2012-08-09
    End date: 2012-08-11

Imatinib Mesylate
    Dosage: 450 mg, per day
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-13

Granisetron
    Dosage: 3 mg, per day
    Start date: 2012-08-16

Mercaptopurine
    Dosage: 1x87.5mg/d average
    Administration route: Oral
    Start date: 2012-08-06

Cytarabine
    Dosage: 110 mg, per day
    Start date: 2012-08-16

Amphotericin B
    Dosage: 6x60 mg/d
    Administration route: Oral
    Start date: 2012-06-24

Pantoprazole
    Dosage: 40 mg, per day
    Administration route: Oral
    Start date: 2012-06-24
    End date: 2012-08-15



Possible Amphotericin B side effects in 63 year old male

Reported by a pharmacist from United States on 2012-08-16

Patient: 63 year old male

Reactions: Drug Intolerance, Gastrointestinal Disorder

Drug(s) suspected as cause:
Itraconazole
    Administration route: Oral
    Indication: Histoplasmosis
    Start date: 2006-06-01
    End date: 2007-03-01

Amphotericin B
    Dosage: for 2 weeks
    Indication: Histoplasmosis
    Start date: 2006-06-01

Corticosteroids
    Indication: Histoplasmosis

Tacrolimus
    Indication: Histoplasmosis

Other drugs received by patient: Azathioprine Sodium; Mycophenolate Mofetil; Cyclosporine; Sirolimus



Possible Amphotericin B side effects in 48 year old male

Reported by a physician from United States on 2012-08-16

Patient: 48 year old male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia Cryptococcal, Anaphylactic Reaction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Administration route: Oral
    Start date: 2012-01-08
    End date: 2012-01-28

Prednisone TAB
    Indication: Kidney Transplant Rejection

Cellcept
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-02-14

Cellcept
    Administration route: Oral

Prednisone TAB
    Start date: 2011-08-18

Sirolimus
    Administration route: Oral
    Indication: Prophylaxis Against Transplant Rejection
    Start date: 2010-06-25
    End date: 2012-01-31

Amphotericin B
    Indication: Pneumonia Cryptococcal
    Start date: 2012-01-08
    End date: 2012-01-28

Cellcept
    Administration route: Oral
    Start date: 2012-01-31

Other drugs received by patient: Humalog; Amlodipine; Lantus; Aspirin; Moxifloxacin; Pantoprazole; Lantus



Possible Amphotericin B side effects in 4 year old male

Reported by a physician from Brazil on 2012-08-14

Patient: 4 year old male

Reactions: NO Therapeutic Response

Adverse event resulted in: death

Drug(s) suspected as cause:
Amphotericin B
    Indication: Fusarium Infection

Voriconazole
    Indication: Fusarium Infection



Possible Amphotericin B side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: 52 year old female

Reactions: Histoplasmosis, Drug Level Below Therapeutic

Drug(s) suspected as cause:
Amphotericin B
    Dosage: 13 days
    Start date: 2007-12-01

Tacrolimus
    Indication: Histoplasmosis

Itraconazole
    Dosage: twice a day to three times a day, because of phenytoin
    Administration route: Oral
    Indication: Histoplasmosis
    Start date: 2005-03-01
    End date: 2007-01-01

Sirolimus
    Indication: Histoplasmosis

Itraconazole
    Administration route: Oral
    Start date: 2007-12-01
    End date: 2009-01-01

Amphotericin B
    Dosage: for 16 days
    Indication: Histoplasmosis
    Start date: 2005-03-01

Other drugs received by patient: Phenytoin



Possible Amphotericin B side effects in 4 year old male

Reported by a physician from Brazil on 2012-08-09

Patient: 4 year old male

Reactions: NO Therapeutic Response

Adverse event resulted in: death

Drug(s) suspected as cause:
Voriconazole
    Indication: Fusarium Infection

Amphotericin B
    Indication: Fusarium Infection



Possible Amphotericin B side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Morocco on 2012-08-05

Patient: 71 year old male

Reactions: Disseminated Cryptococcosis, General Physical Health Deterioration, Loss of Consciousness

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Flucytosine
    Indication: Disseminated Cryptococcosis

Amphotericin B
    Indication: Disseminated Cryptococcosis

Azathioprine Sodium
    Dosage: 100 mg
    Indication: Pemphigus

Prednisone TAB
    Dosage: 10 mg
    Indication: Pemphigus



Possible Amphotericin B side effects in

Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-08-02

Patient:

Reactions: Squamous Cell Carcinoma, NO Therapeutic Response

Drug(s) suspected as cause:
Itraconazole
    Dosage: between 200 mg day 1 and 400 mg day 1 depending on the severity of the lesion.
    Indication: Chromoblastomycosis

Amphotericin B
    Dosage: when necessary
    Indication: Chromoblastomycosis



Possible Amphotericin B side effects in 33 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: 33 year old male, weighing 93.0 kg (204.6 pounds)

Reactions: Lactobacillus Infection, Blood PH Increased, Tachycardia, Blood PH Decreased, Device Related Infection, Scleral Haemorrhage, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Blood Bicarbonate Increased, Acute Respiratory Failure, Renal Failure Acute, Febrile Neutropenia, Haemodialysis, Alopecia, Treatment Failure, Base Excess Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vancomycin
    Indication: Product Used FOR Unknown Indication

Daunorubicin HCL
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-30
    End date: 2012-04-01

Daunorubicin HCL
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-14
    End date: 2012-04-16

Imipenem and Cilastatin
    Dosage: 1000 mg, q8 hours intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-05-07
    End date: 2012-05-28

Caspofungin Acetate
    Dosage: see image
    Indication: Infection
    Start date: 2012-04-09

Caspofungin Acetate
    Dosage: see image
    Indication: Infection
    Start date: 2012-04-08
    End date: 2012-04-08

Caspofungin Acetate
    Dosage: see image
    Indication: Infection
    Start date: 2012-05-20
    End date: 2012-05-22

Voriconazole
    Dosage: 522 mg, q12 hours, intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-08
    End date: 2012-05-08

Penicillin G
    Dosage: 24000000 u, q24 hrs intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-05-04
    End date: 2012-05-09

Amphotericin B
    Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
    Indication: Fungal Infection
    Start date: 2012-05-06
    End date: 2012-05-08

Amphotericin B
    Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
    Indication: Infection Prophylaxis
    Start date: 2012-05-06
    End date: 2012-05-08

Aztreonam
    Dosage: see image
    Indication: Bacterial Infection
    Start date: 2012-05-06
    End date: 2012-05-07

Aztreonam
    Dosage: see image
    Indication: Bacterial Infection
    Start date: 2012-04-09
    End date: 2012-04-10

Cefepime
    Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-03-29
    End date: 2012-04-10

Cefepime
    Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-06-02
    End date: 2012-06-05

(Investigational Drug)
    Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-17
    End date: 2012-04-23

(Investigational Drug)
    Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-02
    End date: 2012-04-08

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-14
    End date: 2012-04-20

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-30
    End date: 2012-04-05

Other drugs received by patient: Ondansetron; Seroquel; Percocet; Nystatin; Zyloprim; Acetaminophen; Calcium Carbonate; Lorazepam; Xanax; Allopurinol; Calcium Gluconate; Ibuprofen; Hydroxyzine Pamoate; Celexa



Possible Amphotericin B side effects in 57 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: 57 year old male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Itraconazole
    Indication: Fungal Infection

Amphotericin B
    Indication: Fungal Infection

Other drugs received by patient: Prednisone; Tacrolimus; Mycophenolate Mofetil



Possible Amphotericin B side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: 67 year old male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Amphotericin B
    Dosage: for 3 months
    Indication: Fungal Infection

Itraconazole
    Indication: Fungal Infection

Amphotericin B-Deoxycholate
    Dosage: for 4 days
    Indication: Fungal Infection

Other drugs received by patient: Prednisone; Azathioprine; Tacrolimus



Possible Amphotericin B side effects in 14 year old female

Reported by a physician from Japan on 2012-07-23

Patient: 14 year old female

Reactions: Renal Impairment, Drug Ineffective, Acute Graft Versus Host Disease, Acute Graft Versus Host Disease in Skin

Drug(s) suspected as cause:
Amphotericin B

Prograf
    Indication: Unrelated Donor Bone Marrow Transplantation Therapy

Other drugs received by patient: Dopamine HCL



Possible Amphotericin B side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-03

Patient:

Reactions: Fungal Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Itraconazole
    Dosage: for a median total duration of 18 months
    Indication: Histoplasmosis

Mycophenolate Mofetil
    Indication: Blastomycosis

Cyclosporine
    Indication: Blastomycosis

Corticosteroids
    Indication: Blastomycosis

Cyclosporine
    Indication: Histoplasmosis

Tacrolimus
    Indication: Histoplasmosis

Amphotericin B
    Indication: Blastomycosis

Amphotericin B
    Indication: Histoplasmosis

Tacrolimus
    Indication: Blastomycosis

Mycophenolate Mofetil
    Indication: Histoplasmosis

Corticosteroids
    Indication: Histoplasmosis

Sirolimus
    Indication: Blastomycosis

Azathioprine
    Indication: Blastomycosis

Itraconazole
    Dosage: for a median total duration of 18 months
    Indication: Blastomycosis

Sirolimus
    Indication: Histoplasmosis

Azathioprine
    Indication: Histoplasmosis



Possible Amphotericin B side effects in male

Reported by a physician from Greece on 2012-07-02

Patient: male, weighing 166.7 kg (366.6 pounds)

Reactions: Anaphylactic Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ceftazidime
    Dosage: iv
    Indication: Pyrexia
    Start date: 2011-12-02
    End date: 2011-12-20

Teicoplanin (NO Pref. Name)
    Dosage: iv
    Indication: Pyrexia
    Start date: 2011-12-02
    End date: 2011-12-18

Amphotericin B
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-08
    End date: 2011-12-08

Cyclosporine
    Dosage: po
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2011-11-11



Possible Amphotericin B side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient:

Reactions: Drug Level Below Therapeutic, Histoplasmosis

Drug(s) suspected as cause:
Mycophenolate Mofetil
    Indication: Histoplasmosis

Cyclosporine
    Indication: Histoplasmosis

Tacrolimus
    Indication: Histoplasmosis

Itraconazole
    Administration route: Oral
    Indication: Histoplasmosis

Azathioprine
    Indication: Histoplasmosis

Amphotericin B
    Indication: Histoplasmosis

Corticosteroids
    Indication: Histoplasmosis

Sirolimus
    Indication: Histoplasmosis



Possible Amphotericin B side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient:

Reactions: Gastrointestinal Disorder, Drug Intolerance

Drug(s) suspected as cause:
Azathioprine
    Indication: Histoplasmosis

Amphotericin B
    Indication: Histoplasmosis

Cyclosporine
    Indication: Histoplasmosis

Mycophenolate Mofetil
    Indication: Histoplasmosis

Sirolimus
    Indication: Histoplasmosis

Itraconazole
    Administration route: Oral
    Indication: Histoplasmosis

Tacrolimus
    Indication: Histoplasmosis

Corticosteroids
    Indication: Histoplasmosis



Possible Amphotericin B side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient:

Reactions: Blastomycosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Sirolimus
    Indication: Blastomycosis

Azathioprine
    Indication: Blastomycosis

Itraconazole
    Indication: Blastomycosis

Mycophenolate Mofetil
    Indication: Blastomycosis

Amphotericin B
    Indication: Blastomycosis

Tacrolimus
    Indication: Blastomycosis

Corticosteroids
    Indication: Blastomycosis

Cyclosporine
    Indication: Blastomycosis



Possible Amphotericin B side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient:

Reactions: Histoplasmosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Amphotericin B
    Indication: Histoplasmosis

Cyclosporine
    Indication: Histoplasmosis

Sirolimus
    Indication: Histoplasmosis

Azathioprine
    Indication: Histoplasmosis

Tacrolimus
    Indication: Histoplasmosis

Mycophenolate Mofetil
    Indication: Histoplasmosis

Itraconazole
    Dosage: once or twice daily for a median duration of 8 months (range 1-13)
    Indication: Histoplasmosis

Corticosteroids
    Indication: Histoplasmosis



Possible Amphotericin B side effects in 55 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13

Patient: 55 year old female

Reactions: Liver Injury, Zygomycosis, Pneumothorax, Pleural Effusion, Febrile Neutropenia, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Amphotericin B
    Indication: Antifungal Prophylaxis

Caspofungin Acetate
    Indication: Zygomycosis

Amphotericin B
    Indication: Zygomycosis

Anti-Thymocyte Globulin NOS
    Indication: Prophylaxis Against Graft Versus Host Disease

Levofloxacin
    Indication: Antibiotic Prophylaxis

Voriconazole
    Indication: Antifungal Prophylaxis

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Defarasirox
    Indication: Zygomycosis

Fluconazole
    Indication: Antifungal Prophylaxis

Busulfan
    Indication: Stem Cell Transplant

Methotrexate
    Indication: Prophylaxis Against Graft Versus Host Disease

Cyclophosphamide
    Indication: Stem Cell Transplant

Piperacillin / Tazobactam
    Indication: Febrile Neutropenia



Possible Amphotericin B side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-12

Patient:

Reactions: Renal Failure, Medication Error, Anaemia, Electrolyte Imbalance, Drug Dispensing Error

Drug(s) suspected as cause:
Amphotericin B

Amphotericin B



Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-11

Patient: 43 year old male

Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Device Related Infection, Death, Renal Failure, Sepsis Syndrome, Renal Impairment, Cardio-Respiratory Arrest, Cardiac Failure, Respiratory Failure, Hallucination, Visual, Neutropenia, Mycobacterium Fortuitum Infection, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ciprofloxacin HCL
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Clarithromycin
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Oseltamivir
    Dosage: 75 mg, 2x/day
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Immunosuppression

Amphotericin B
    Indication: Aspergillosis

Prednisolone
    Dosage: 60 mg, unk
    Indication: Immunosuppression

Ciprofloxacin HCL
    Dosage: 60 mg

Voriconazole
    Dosage: unk
    Indication: Aspergillosis

Teicoplanin
    Dosage: 400 mg, 1x/day
    Indication: Product Used FOR Unknown Indication

Meropenem
    Dosage: 1 g, 2x/day
    Indication: Product Used FOR Unknown Indication



Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) on 2012-06-08

Patient: 43 year old male

Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Neutropenic Sepsis, Cholestasis, H1n1 Influenza, Haemodialysis, Cardio-Respiratory Arrest, Hallucination, Visual, Cardiac Failure, Mycobacterium Fortuitum Infection, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ciprofloxacin
    Dosage: 1000 mg (500 mg, 2 in 1 d),
    Indication: Mycobacterium Fortuitum Infection

Clarithromycin
    Dosage: 1000 mg (500 mg, 2 in 1 d),
    Indication: Mycobacterium Fortuitum Infection

Teicoplanin (Teicoplanin)
    Dosage: 400 mg (400 mg, 1 in 1 d), parenteral
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 100 mg (100 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Immunosuppression

Oseltamivir Phosphate
    Dosage: 150 mg (75 mg, 2 in 1 d), parenteral
    Indication: Product Used FOR Unknown Indication

Prednisolone
    Dosage: 60 mg,
    Indication: Immunosuppression

Voriconazole
    Indication: Aspergillosis

Meropenem
    Dosage: 2 gm (1 gm, 2 in 1 d), parenteral
    Indication: Product Used FOR Unknown Indication

Amphotericin B
    Indication: Aspergillosis



Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-05

Patient: 43 year old male

Reactions: Liver Injury, Right Ventricular Failure, Dyspnoea, Haemoptysis, Cholestasis, Cardio-Respiratory Arrest, Sepsis Syndrome, Respiratory Failure, Aspergillosis, Neutropenia, Mycobacterium Fortuitum Infection, Renal Failure Acute, Influenza A Virus Test Positive

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisolone
    Dosage: 60 mg, daily
    Administration route: Oral
    Indication: Renal Vasculitis

Ciprofloxacin HCL
    Dosage: 500 mg, bid
    Indication: Mycobacterium Fortuitum Infection

Meropenem
    Dosage: 1 g, bid
    Indication: Sepsis Syndrome

Amikacin
    Indication: Mycobacterium Fortuitum Infection

Amphotericin B
    Indication: Aspergillosis

Prednisolone
    Indication: Pulmonary Vasculitis

Voriconazole
    Dosage: unk
    Indication: Aspergillosis

Cyclophosphamide
    Indication: Pulmonary Vasculitis

Oseltamivir
    Dosage: 75 mg, bid
    Indication: Sepsis Syndrome

Clarithromycin
    Dosage: 500 mg, bid
    Indication: Mycobacterium Fortuitum Infection

Teicoplanin
    Dosage: 400 mg, daily
    Indication: Sepsis Syndrome

Cyclophosphamide
    Dosage: 100 mg, daily
    Administration route: Oral
    Indication: Renal Vasculitis



Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30

Patient: 43 year old male

Reactions: Liver Injury, Device Related Infection, Death, Cardio-Respiratory Arrest, Mycobacterium Fortuitum Infection, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Sepsis Syndrome, Renal Failure, Renal Impairment, Cardiac Failure, Hallucination, Visual, Respiratory Failure, Neutropenia, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ciprofloxacin HCL
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Prednisolone
    Dosage: 60 mg, unk
    Indication: Immunosuppression

Oseltamivir
    Indication: Product Used FOR Unknown Indication

Teicoplanin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Immunosuppression

Clarithromycin
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Voriconazole
    Dosage: unk
    Indication: Aspergillosis

Meropenem
    Indication: Product Used FOR Unknown Indication

Amphotericin B
    Indication: Aspergillosis



Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) on 2012-05-30

Patient: 43 year old male

Reactions: Bronchopulmonary Aspergillosis, Liver Injury, Haemoptysis, Neutropenic Sepsis, Device Related Infection, H1n1 Influenza, Renal Failure, Cardio-Respiratory Arrest, Hallucination, Visual, Cardiac Failure, Respiratory Failure, Mycobacterium Fortuitum Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Teicoplanin (Teicoplanin)
    Indication: Product Used FOR Unknown Indication

Voriconazole
    Indication: Product Used FOR Unknown Indication

Clarithromycin
    Dosage: 1000 mg (500 mg, 2 in 1 d)
    Indication: Mycobacterium Fortuitum Infection

Prednisolone
    Dosage: 60 mg
    Indication: Immunosuppression

Oseltamivir Phosphate
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 100 mg (100 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Immunosuppression

Amphotericin B
    Indication: Aspergillosis

Ciprofloxacin
    Dosage: 1000 mg (500 mg, 2 in 1 d)
    Indication: Mycobacterium Fortuitum Infection

Meropenem
    Indication: Product Used FOR Unknown Indication



Possible Amphotericin B side effects in 47 year old female

Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-05-30

Patient: 47 year old female, weighing 68.0 kg (149.6 pounds)

Reactions: Hepatomegaly, Respiratory Disorder, Respiratory Tract Haemorrhage, Candidiasis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Tretinoin
    Dosage: 40 mg/m2/day continuously
    Administration route: Oral
    Indication: Acute Promyelocytic Leukaemia

Metamizole
    Dosage: 500 mg
    Administration route: Oral
    Indication: Febrile Neutropenia

Fluconazole
    Dosage: 200 mg/day
    Administration route: Oral
    Indication: Candidiasis

Mitoxantrone
    Dosage: 20 mg/m2/day
    Indication: Acute Promyelocytic Leukaemia

Amphotericin B
    Dosage: 30 mg/day, 6 hours of infusion
    Indication: Candidiasis

Cytarabine
    Dosage: 370 mg/m2/day
    Indication: Acute Promyelocytic Leukaemia

Cefepime
    Dosage: 2 g, every eight hours
    Indication: Febrile Neutropenia

Other drugs received by patient: Meropenem; Methotrexate; Tretinoin



Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-28

Patient: 43 year old male

Reactions: Bronchopulmonary Aspergillosis, Liver Injury, Renal Failure, Endocarditis Bacterial, Cardiac Failure, Neutropenic Sepsis, H1n1 Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Meropenem

Amikacin

Cyclophosphamide
    Administration route: Oral
    Indication: Vasculitis

Clarithromycin
    Indication: Infection

Amphotericin B

Voriconazole

Prednisolone
    Administration route: Oral
    Indication: Vasculitis

Ciprofloxacin
    Indication: Infection

Teicoplanin

Oseltamivir Phosphate



Possible Amphotericin B side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-05-22

Patient: 29 year old female

Reactions: Drug Ineffective, Candida Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Micafungin
    Dosage: 100 mg, uid/qd
    Indication: Lung Transplant

Amphotericin B
    Dosage: 250 mg, uid/qd
    Indication: Lung Transplant

Other drugs received by patient: Basiliximab; Tacrolimus; Mycophenolate Mofetil; Corticosteroid NOS



Possible Amphotericin B side effects in male

Reported by a physician from Korea, Republic of on 2012-05-10

Patient: male, weighing 55.0 kg (121.0 pounds)

Reactions: Pneumonia Fungal, Fatigue, Aspergillus Test Positive, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Pertuzumab
    Dosage: date of most recent dose prior to sae: 18/jan/2012
    Indication: Gastric Cancer
    Start date: 2011-12-21

Amphotericin B
    Indication: Product Used FOR Unknown Indication

Herceptin
    Dosage: date of most recent dose prior to sae: 18/jan/2012
    Indication: Gastric Cancer
    Start date: 2011-12-21

Cisplatin
    Dosage: date of most recent dose prior to sae: 18/jan/2012
    Indication: Gastric Cancer
    Start date: 2011-12-21

Xeloda
    Dosage: date of most recent dose prior to sae: 31/jan/2012
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2011-12-21

Voriconazole
    Indication: Product Used FOR Unknown Indication



Possible Amphotericin B side effects in 26 year old male

Reported by a physician from United States on 2012-05-01

Patient: 26 year old male

Reactions: Histoplasmosis, Small Intestinal Obstruction, Small Intestinal Perforation

Drug(s) suspected as cause:
Amphotericin B

Antiretrovirals (Nos)
    Indication: Product Used FOR Unknown Indication

Amphotericin B
    Indication: Histoplasmosis

Itraconazole
    Administration route: Oral
    Indication: Histoplasmosis

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014